Compliance assessment in drug trials: Has there been improvement in two decades?

Canadian Journal of Clinical Pharmacology

Volumn 12, Issue 3, 2005, Pages

  Jayaraman, Shiva ^a   Rieder, Michael J ^a   Matsui, Doreen M ^a  

^a CHILDREN S HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Assessment; Compliance; Drug trial

Indexed keywords

ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; DRUG DETERMINATION; DRUG EFFICACY; DRUG RESEARCH; HUMAN; MEASUREMENT; PRACTICE GUIDELINE; SELF REPORT;

EID: 30744448182     PISSN: 1198581X     EISSN: 17106222     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. nd ed. Boston, MA: Little, Brown and Company, 1991:249-81.
2. Matsui D. Drug Compliance in Pediatrics: Clinical and Research Issues. Pediatr Clin North Am 1997;44:1-14.
3. Soutter BR, Kennedy MC. Patient Compliance Assessment in Drug Trials: Usage and Methods. Aust NZ J Med. 1974;4:360-4.
4. Kastrissios H, Blaschke TF. Medication Compliance as a Feature in Drug Development. Annu Rev Pharmacol Toxicol 1997;37:451-75.
5. Boudes P. Drug Compliance in Therapeutic Trials: A Review. Control Clin Trials 1998;19:257-68